Appendix 2—table 21. “Bone-Rx” Cohort (Region=West), Patient Characteristics Pre/Post Match.
| "Bone-Rx" Cohort / Region=West Unmatched | "Bone-Rx" Cohort / Region=West Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 103,519 | 100.0% | 8,049 | 7.8% | 95,470 | 92.2% | 16,010 | 100.0% | 8,005 | 50.0% | 8,005 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 155 | 0.1% | ≤10 | 0.1% | 150 | 0.2% | <0.001 | ≤10 | 0.0% | ≤10 | 0.1% | ≤10 | 0.0% | 0.96 |
| 21-40 | 625 | 0.6% | 68 | 0.8% | 557 | 0.6% | 124 | 0.8% | 67 | 0.8% | 57 | 0.7% | ||
| 41-50 | 1,539 | 1.5% | 135 | 1.7% | 1,404 | 1.5% | 264 | 1.6% | 135 | 1.7% | 129 | 1.6% | ||
| 51-60 | 11,159 | 10.8% | 779 | 9.7% | 10,380 | 10.9% | 1,556 | 9.7% | 776 | 9.7% | 780 | 9.7% | ||
| 61-70 | 33,497 | 32.4% | 2,105 | 26.2% | 31,392 | 32.9% | 4,200 | 26.2% | 2,101 | 26.2% | 2,099 | 26.2% | ||
| 71-80 | 35,036 | 33.8% | 2,598 | 32.3% | 32,438 | 34.0% | 5,182 | 32.4% | 2,588 | 32.3% | 2,594 | 32.4% | ||
| ≥81 | 21,508 | 20.8% | 2,359 | 29.3% | 19,149 | 20.1% | 4,676 | 29.2% | 2,333 | 29.1% | 2,343 | 29.3% | ||
| Gender | ||||||||||||||
| Female | 91,615 | 88.5% | 6,942 | 86.2% | 84,673 | 88.7% | <0.001 | 13,850 | 86.5% | 6,922 | 86.5% | 6,928 | 86.5% | 0.89 |
| Male | 11,904 | 11.5% | 1,107 | 13.8% | 10,797 | 11.3% | 2,160 | 13.5% | 1,083 | 13.5% | 1,077 | 13.5% | ||
| Insurance | ||||||||||||||
| Commercial | 25,514 | 24.6% | 2,172 | 27.0% | 23,342 | 24.4% | <0.001 | 4,299 | 26.9% | 2,152 | 26.9% | 2,147 | 26.8% | 1.00 |
| Dual | 6,664 | 6.4% | 528 | 6.6% | 6,136 | 6.4% | 1,044 | 6.5% | 525 | 6.6% | 519 | 6.5% | ||
| Medicaid | 26,870 | 26.0% | 2,376 | 29.5% | 24,494 | 25.7% | 4,723 | 29.5% | 2,361 | 29.5% | 2,362 | 29.5% | ||
| Medicare | 44,471 | 43.0% | 2,973 | 36.9% | 41,498 | 43.5% | 5,944 | 37.1% | 2,967 | 37.1% | 2,977 | 37.2% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 33,113 | 32.0% | 2,289 | 28.4% | 30,824 | 32.3% | <0.001 | 4,546 | 28.4% | 2,277 | 28.4% | 2,269 | 28.3% | 0.89 |
| Yes | 70,406 | 68.0% | 5,760 | 71.6% | 64,646 | 67.7% | 11,464 | 71.6% | 5,728 | 71.6% | 5,736 | 71.7% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.17 | 1.94 | 2.17 | 2.67 | 1.08 | 1.84 | <0.001 | 2.12 | 2.59 | 2.12 | 2.59 | 2.12 | 2.59 | 0.93 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.